Sifat Sharmin

15PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 21, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

|Jul 28, 2025
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years.

Jodie I Roberts, Sifat Sharmin, Dana Horakova

|Nov 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.

Pakeeran Siriratnam, Saif Huda, Anneke Van Der Walt

|Sep 04, 2024
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study.

Pakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt

Pageof 3

Frequent Collaborators

12 joint publications

Tomas Kalincik

9 joint publications

Izanne Roos

8 joint publications

Anneke van der Walt

6 joint publications

Samia Joseph Khoury